IRS 4 a constitutive active oncogenic driver causing therapy resistance Author ' s View Insulin receptor substrate 4 ( IRS 4 ) is a constitutive active oncogenic driver collaborating with HER 2 and causing therapeutic resistance

semanticscholar（2017）

引用 0|浏览0

暂无评分

摘要

Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance Gerjon J. Ikink & John Hilkens To cite this article: Gerjon J. Ikink & John Hilkens (2017): Insulin receptor substrate 4 (IRS4) is a constitutive active oncogenic driver collaborating with HER2 and causing therapeutic resistance, Molecular & Cellular Oncology, DOI: 10.1080/23723556.2017.1279722 To link to this article: http://dx.doi.org/10.1080/23723556.2017.1279722

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要